August 2023 — Clinical researchers at Semmelweis University in Hungary announced they will use Mitra® microsampling devices donated by Trajan Scientific and Medical (Trajan) to conduct a neonate research study.
The donated Mitra devices enable the researchers to evaluate new sampling methods and develop less invasive blood tests for newborn and premature babies.
The Mitra device is based on volumetric absorptive microsampling, which absorbs a micro-volume blood sample of just 10, 20, or 30 µL. Mitra devices are based on patented VAMS® technology.
A newborn baby has only about 80 ml of blood per kilogram of body weight, so it is important to minimize the amount of blood taken from them for testing to avoid a negative impact on their health and well-being. The Mitra device collects microsamples that are less than one-tenth of the blood sample size required for standard laboratory measurements.
“In terms of laboratory measurements of newborns and premature babies, this quantitative difference is significant, since compared to their total blood volume, the amount of blood required for laboratory tests already represents a significant loss,” said Dr. Kata Kovács, assistant lecturer at the Pediatric Center.
The studies will compare steroid levels from capillary blood samples (10 microliters) and standard arterial blood samples (200 microliters) to facilitate clinical application of the new sampling method. The donated devices from Trajan have made implementation of the two-year research plan possible.
The technical expertise for the study is provided by the Laboratory of Mass Spectrometry and Separation Technology, Department of Laboratory Medicine, Semmelweis University.
About the Pediatric Center of Semmelweis University
About Neoteryx, Microsampling Solutions by Trajan
Neoteryx, a world leader in microsampling devices, was acquired by Trajan in 2021. Today, Trajan’s full line of microsampling solutions carry the Neoteryx brand. The Neoteryx range of microsampling products provide precise, quantitative remote specimen collection. They are easy to use, virtually painless, and amenable to automated analysis in the lab, easing workflows and enabling decentralized research and healthcare models. The product portfolio includes the Mitra® device based on VAMS® technology and the hemaPEN® that advances both capillary and dried blood spot (DBS) technologies, with more microsampling products in the pipeline. For more information on microsampling solutions, visit www.neoteryx.com.
# # #
Media Contacts:
Semmelweis University: press@semmelweis.hu
Trajan: Amy Miller, WE Communications, amymi@we-worldwide.com
Image Credits: Trajan, Neoteryx, iStock, Semmelweis University